The next breakthrough in drug discovery is a team of Virtual Scientists that designs, runs and interprets complex experiments by intelligently using the right software and data. Kiin AI is bringing this vision to life with KiinOS
Kiin Bio has raised €1.9M across 1 funding round from 4 investors, most recently a Pre-Seed round in Jun 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-05 | Pre-Seed | €1.9M |
| b2venture ,Business Angels,Heartfelt,rule30 |
| View deal → |
